Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Combination Fluticason Furoate | Vilanterol Trifenatate - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Combination Indacaterol Maleate | Glycopyrronium Bromide - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Abatacept - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Agalsidase Beta - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Tobramycin (hpi) - Vv 80 2026-08-10
Paraguay Acquisition Of Various Medical Supplies 2026-08-10
Tunisia Acquisition Of Medical Devices And Liquid Solutions For Hemodialysis 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Aclidinium Bromide (atc Code 2026-08-10
United Kingdom Digital Medical Evidence Solution 2026-08-10
Germany Disposal Of Blood Irradiation Devices 2026-08-10
Whats app